Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · IEX Real-Time Price · USD
0.650
-0.055 (-7.84%)
At close: Jul 2, 2024, 4:00 PM
0.640
-0.010 (-1.54%)
After-hours: Jul 2, 2024, 7:58 PM EDT

Bluejay Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
02850--
Market Cap Growth
-74.22%-80.25%-84.67%---
Enterprise Value
-2-0-23101
PE Ratio
--0.15-0.82-14.31--
PS Ratio
--30.74---
PB Ratio
0.110.520.662.45--
P/FCF Ratio
-0.27-0.17-0.86-11.37--
P/OCF Ratio
-0.28-0.18-0.99-11.43--
EV/Sales Ratio
---7.90---
EV/EBITDA Ratio
0.020.040.22-10.38-0.15-1.56
EV/EBIT Ratio
0.020.030.21-9.89-0.13-1.27
EV/FCF Ratio
0.020.040.22-7.03-0.28-0.57
Debt / Equity Ratio
0.090.120.04--0.25-0.36
Debt / EBITDA Ratio
-0.03-0.04-0.05--1.08-1.71
Debt / FCF Ratio
-0.04-0.04-0.06--2.08-0.63
Quick Ratio
1.741.256.1729.890.490.17
Current Ratio
2.261.827.1932.430.570.52
Asset Turnover
000.0200-
Interest Coverage
----8.49-41.90-14.68
Return on Equity (ROE)
-218.30%-168.40%-61.50%-43.10%32.50%-
Return on Assets (ROA)
-146.10%-122.60%-55.20%-31.00%-95.20%-
Return on Capital (ROIC)
-273.09%-317.48%-77.43%-15.85%37.98%87.56%
Earnings Yield
-2657.72%-658.43%-121.44%-6.99%--
FCF Yield
-2202.90%-596.53%-116.78%-8.79%--
Buyback Yield / Dilution
-131.59%-8.76%-136.60%-170.79%--
Total Shareholder Return
-131.59%-8.76%-136.60%-170.79%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).